Novel TSC1 and TSC2 Gene Mutations in Chinese Patients with Tuberous Sclerosis Complex.

Tingting Yu,Yingzhong He,Niu Li,Yunqing Zhou,Zhiping Wang,Qihua Fu,Jiwen Wang,Jian Wang

DOI: https://doi.org/10.1016/j.clineuro.2017.01.015

IF: 1.885

2017-01-01

Clinical Neurology and Neurosurgery

Abstract:Objective: The study was designed to identify pathogenic TSC1 or TSC2 gene mutations and provide solid evidence for the diagnosis of tuberous sclerosis complex (TSC).Methods: 11 unrelated Chinese patients with TSC were investigated in the present study. Characteristic skin lesions such as hypomelanotic macules and the central nervous system features such as the epilepsy, cortical tubers and subependymal nodules were the most common symptoms that were observed in the patients. All exons and exon-intron boundaries of the TSCI and TSC2 gene of the patients were amplified by PCR.Results: A total of 11 different TSC2 and one TSCI mutations were identified in the present study, of which five TSC2 and 1 TSCI gene mutations were novel. Among the 11 patients, 10 harbored TSC2 mutations, whereas only one patient had a TSCI gene mutation. The identification of TSCl/TSC2 gene mutations confirmed the diagnosis of the 11 patients with TSC.Conclusions: Our study has expanded the spectrum of TSCI and TSC2 gene mutations causing TSC. The identification of the TSCI/TSC2 gene mutations confirmed the diagnosis of the 11 patients with TSC. (C) 2017 Elsevier B.V. All rights reserved.